Pakistan Business News API

{
    "totalArticles": 331780,
    "articles": [
        {
            "id": "1d9d173cff41fbc7837255db9e1c1184",
            "title": "China opposes Pentagon move against top firms (BABA:NYSE)",
            "description": "China opposes the Pentagon's decision to designate some of its leading tech firms, including Alibaba (BABA) and Baidu (BIDU), as military firms. Read more here.",
            "content": "China opposes Pentagon move against top firms including Alibaba, Baidu, Nio\nComments\n(21)\nChina on Saturday raised concerns over the Pentagon's recent decision to designate some of its leading tech firms, including Alibaba (BABA) and Baidu (BIDU), as... [260 chars]",
            "url": "https://seekingalpha.com/news/4603105-china-opposes-pentagon-move-against-top-firms",
            "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2204624068/image_2204624068.jpg?io=getty-c-w630",
            "publishedAt": "2026-06-13T15:16:59Z",
            "lang": "en",
            "source": {
                "id": "3c5f57e561d9315a8a9a86be8720511e",
                "name": "Seeking Alpha",
                "url": "https://seekingalpha.com"
            }
        },
        {
            "id": "b74711779aaae3c98eb7b79edd169114",
            "title": "Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting",
            "description": "/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data from the Phase 1 AJX-101 study showing that its investigational type II JAK2...",
            "content": "INDIANAPOLIS, June 13, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data from the Phase 1 AJX-101 study showing that its investigational type II JAK2 inhibitor (AJ1-11095) demonstrated an encouraging safety profile and p... [8060 chars]",
            "url": "https://www.prnewswire.com/news-releases/lilly-to-present-initial-clinical-data-for-first-in-class-type-ii-jak2-inhibitor-in-patients-with-previously-treated-myelofibrosis-at-the-2026-eha-annual-meeting-302799309.html",
            "image": "https://mmx.prnewswire.com/media/MS270365/ELI_LILLY_AND_COMPANY_LOGO.jpg?id=OA2698378&p=facebook",
            "publishedAt": "2026-06-13T15:15:00Z",
            "lang": "en",
            "source": {
                "id": "4e4307a07d2ce1e31acaf932954d3dd9",
                "name": "PR Newswire",
                "url": "https://www.prnewswire.com"
            }
        },
        {
            "id": "d3a409566fd4c571277adc8f640de600",
            "title": "SpaceX Just Made The AI Infrastructure War Public",
            "description": "SpaceX’s IPO wasn’t just about rockets. It was a bet on who controls the physical infrastructure the next AI economy will run on.",
            "content": "Wall Street thinks it bought rockets and broadband. The more interesting bet is whether SpaceX now controls more of AI's physical layer than almost anyone else.\nThe more revealing number was not on the launchpad. It was in the prospectus.\nAhead of th... [4504 chars]",
            "url": "https://www.forbes.com/sites/robertszczerba/2026/06/13/spacex-just-made-the-ai-infrastructure-war-public/",
            "image": "https://imageio.forbes.com/specials-images/imageserve/6a2d55a3f34ad010e53648bb/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "publishedAt": "2026-06-13T13:48:35Z",
            "lang": "en",
            "source": {
                "id": "c4e32b557a3dd75225975f11fb68a3a9",
                "name": "Forbes",
                "url": "https://www.forbes.com"
            }
        }
    ]
}